Implant and Prosthetics Market to Top $10 Billion by 2020



New implant technology has transformed treatment, and the market is responding. In fact, the global dental implants and prosthetics market will grow at a compound annual growth rate of 7.2% from $7.366 billion in 2015 to $10.428 billion in 2020, according to MarketsandMarkets.

Rising rates of dental carries and other periodontal conditions, increasing incidences of tooth loss, and an aging population that’s vulnerable to edentulism are driving this growth. A focus on quality dental care, rising disposable income, and patients’ willingness to spend out-of-pocket will add to the boom, researchers say.

Poor dental insurance coverage for implants and low reimbursement might hinder this expansion, MarketsandMarkets notes. Still, the overall adoption of dental implants is greater than that of dental prosthetics due to the better aesthetics and hygiene associated with their use.

Europe contributed the maximum share of the global implants and prosthetics market in 2014, followed by North America, Asia-Pacific, and the rest of the world. France, Germany, and Switzerland mainly drive the growth of the European market, while the United States dominates North America.

Spain, Hungary, Romania, and Italy, have been attracting many medical tourists—people who travel primarily to obtain medical treatment that may be unavailable or too costly at home. Still, MarketsandMarkets expects Europe to show sluggish growth during the forecast period because the market is highly penetrated.

Asia-Pacific and Latin America will grow the fastest from 2015 to 2020, propelled by India, China, Brazil, Mexico, and South Korea. Medical tourism will propel this growth, as travellers seek the low costs and pricing of dental bridges, growing numbers of dentists with expertise, and improvements in healthcare infrastructure in these regions.

Acquisitions and product launches are the main strategies employed by the market’s top players, which include Straumann, DENTSPLY International, Zimmer Holdings, Biomet 3i, 3M ESPE, Danaher Corp., Avinent Implant System, and OSSTEM Implant Co. Ltd.